Basiliximab Intravenous and Clonidine Extended-Release Tablets
Determining the interaction of Basiliximab Intravenous and Clonidine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: basiliximab
Brand name: Simulect
Synonyms: Basiliximab
Generic Name: clonidine
Brand name: Catapres, Kapvay, Catapres-TTS, Duraclon, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3
Synonyms: Clonidine, CloNIDine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Basiliximab Intravenous-Clonidine injection
- Basiliximab Intravenous-Clonidine Oral, Transdermal
- Basiliximab Intravenous-Clonidine Patch
- Basiliximab Intravenous-Clonidine Patches
- Basiliximab Intravenous-Clonidine Tablets
- Basiliximab Intravenous-Clonidine transdermal
- Clonidine Extended-Release Tablets-Bavencio
- Clonidine Extended-Release Tablets-Baxdela
- Clonidine Extended-Release Tablets-Baxdela (Delafloxacin Injection)
- Clonidine Extended-Release Tablets-Baxdela (Delafloxacin Tablets)
- Clonidine Extended-Release Tablets-Baxdela Intravenous
- Clonidine Extended-Release Tablets-Baycadron